Journal of Preventive Medicine and Public Health10.3961/jpmph.17.0902019522140-144Estimating the Survival of Patients With Lung Cancer: What Is the Best Statistical Model?Siavosh Abedi, Ghasem Janbabaei, Mahdi Afshari, Mahmood Moosazadeh, Masoumeh Rashidi Alashti, Akbar Hedayatizadeh-Omran, Reza Alizadeh-Navaei, Ehsan Abedini,,
Clinical Lung Cancer10.1016/j.cllc.2014.05.0012014155313-319ALK Inhibitors: What Is the Best Way to Treat Patients With ALK+ Non–Small-Cell Lung Cancer?Gouji Toyokawa, Takashi Seto,
Lung Cancer10.1016/s0169-5002(86)80417-2198621-2104Median survival: An original approach for long term survival in lung cancer patients,
Lung Cancer10.1016/s0169-5002(19)30178-32019127S55-S56Estimating renal function in lung cancer patientsK. Gannon, S. Ball,
Lung Cancer10.1016/0169-5002(91)91551-l1991755Natural survival of patients with lung cancer detected during cancer screening in Xuan Wei, China,
Lung Cancer10.1016/s0169-5002(00)80476-62000291142-143Homeostasis networks in prognosis of lung cancer patients survivalO Kshivets,
Lung Cancer10.1016/0169-5002(91)91555-p1991756The impact of neuroendocrine and epithelial differentiation on recurrence and survival in patients with lung cancer,
Lung Cancer10.1016/0169-5002(91)91521-c1991748Super-long-term survival over 15 years of 128 postoperative patients with lung cancer,
Lung Cancer10.1016/0169-5002(95)90647-91995132214Prediction of survival time for patients with lung cancer and assessment of therapeutic effect,
Lung Cancer10.1016/0169-5002(91)90177-8199173195Sex-associated differences in presentation and survival in patients with lung cancer,